Literature DB >> 10526742

Augmentation of central arterial pressure in type 1 diabetes.

B Brooks1, L Molyneaux, D K Yue.   

Abstract

OBJECTIVE: Atherosclerosis is more severe in individuals with diabetes. Whether diabetic subjects have accelerated arterial hardening (i.e., arteriosclerosis) is less clear. Arteriosclerosis increases pulse-wave velocity and can augment central arterial pressure due to early wave reflection. The aim of this study was to determine whether subjects with type 1 diabetes had evidence of increased arterial stiffness by using pulse-wave analysis. RESEARCH DESIGN AND METHODS: Radial artery pressure waveforms were obtained noninvasively by applanation tonometry (PWV Medical Blood Pressure Analysis System, Sydney). A central aortic waveform can be derived by using a transfer function used in previous studies during cardiac catheterization. A total of 89 subjects with type 1 diabetes (46 men and 43 women, aged 34.0 +/- 11.0 years, duration of diabetes 13.1 years [interquartile range 5.8-24.3], HbA1c 8.2 +/- 1.7%) and 95 control subjects (44 men and 51 women, aged 36.1 +/- 12.0 years) were studied. The central aortic waveform allowed the determination of 1) the aortic augmentation index (AAI), a parameter that reflects the degree to which central arterial pressure is augmented by wave reflection, and 2) the subendocardial viability ratio (SEVR), which is a measure of myocardial perfusion relative to cardiac workload.
RESULTS: In multivariate analysis, diabetes was an important determinant of AAI (P = 0.001). The higher AAI was mainly evident in the men, for whom diabetes was a highly significant covariate (P = 0.006); this was not the case for diabetic women (P = 0.2). Nondiabetic men had a lower AAI than nondiabetic women (103.7 +/- 18.6 vs. 117.0 +/- 22.3%, respectively, P = 0.002), but this difference was abolished by diabetes (110.7 +/- 18.5 vs. 116.1 +/- 18.7%, respectively, P = 0.2). Subjects with type 1 diabetes had a significantly lower mean SEVR compared with control subjects (139.2 +/- 28.3 vs. 163.6 +/- 27.4%, respectively, P < 0.0001). In multivariate analysis, diabetes was an important determinant of SEVR (P = 0.001). A significant interaction between diabetes and age was evident (P = 0.0001), which suggests that the effect of age is modified by diabetes.
CONCLUSIONS: These findings suggest that central systolic blood pressure is increased in relatively young individuals with type 1 diabetes, although myocardial perfusion related to cardiac workload is decreased. These changes can be explained by more rapid pulse-wave velocity resulting from arterial stiffening.

Entities:  

Mesh:

Year:  1999        PMID: 10526742     DOI: 10.2337/diacare.22.10.1722

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  26 in total

Review 1.  Pulse wave analysis.

Authors:  M F O'Rourke; A Pauca; X J Jiang
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

2.  Smoking and arterial stiffness in youth with type 1 diabetes: the SEARCH Cardiovascular Disease Study.

Authors:  Amy S Shah; Dana Dabelea; Jennifer W Talton; Elaine M Urbina; Ralph B D Agostino; R Paul Wadwa; Santica Marcovina; Richard F Hamman; Stephen R Daniels; Lawrence M Dolan
Journal:  J Pediatr       Date:  2014-03-27       Impact factor: 4.406

3.  Aortic augmentation index is associated with the ankle-brachial index: a community-based study.

Authors:  Mahyar Khaleghi; Iftikhar J Kullo
Journal:  Atherosclerosis       Date:  2007-01-24       Impact factor: 5.162

Review 4.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease.

Authors:  C D A Stehouwer; R M A Henry; I Ferreira
Journal:  Diabetologia       Date:  2008-02-01       Impact factor: 10.122

5.  Arterial stiffness in type 1 diabetes mellitus is aggravated by autoimmune thyroid disease.

Authors:  D Tryfonopoulos; E Anastasiou; A Protogerou; T Papaioannou; K Lily; A Dagre; E Souvatzoglou; C Papamichael; M Alevizaki; J Lekakis
Journal:  J Endocrinol Invest       Date:  2005 Jul-Aug       Impact factor: 4.256

6.  Occurrence of increased arterial stiffness in a cohort of adult patients with type 1 diabetes mellitus when compared to normoglycemic controls.

Authors:  Belinda George; Ganapathi Bantwal; Vageesh Ayyar; Vivek Mathew
Journal:  J Diabetes Sci Technol       Date:  2014-09-17

Review 7.  Aspects of Hyperglycemia Contribution to Arterial Stiffness and Cardiovascular Complications in Patients With Type 1 Diabetes.

Authors:  Daniel Gordin; Per-Henrik Groop
Journal:  J Diabetes Sci Technol       Date:  2016-08-22

8.  Aortic stiffness is associated with cardiac function and cerebral small vessel disease in patients with type 1 diabetes mellitus: assessment by magnetic resonance imaging.

Authors:  Saskia G C van Elderen; A Brandts; J J M Westenberg; J van der Grond; J T Tamsma; M A van Buchem; J A Romijn; L J M Kroft; J W A Smit; A de Roos
Journal:  Eur Radiol       Date:  2009-11-14       Impact factor: 5.315

9.  Effect of direct renin inhibition on renal hemodynamic function, arterial stiffness, and endothelial function in humans with uncomplicated type 1 diabetes: a pilot study.

Authors:  David Z I Cherney; Vesta Lai; James W Scholey; Judith A Miller; Bernard Zinman; Heather N Reich
Journal:  Diabetes Care       Date:  2009-11-04       Impact factor: 19.112

10.  Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes.

Authors:  Catherine T Prince; Aaron M Secrest; Rachel H Mackey; Vincent C Arena; Lawrence A Kingsley; Trevor J Orchard
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.